gastric cancer
Conditions
Sponsors
Hebei University of Chinese Meidicne
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Patients who meet the " Chinese Society of Clinical Oncology (CSCO) Guidelines for Diagnosis and Treatment of Gastric Cancer" (2018.V1) diagnosed as gastric cancer by cytology or histopathology; 2.According to the American Joint Committee on Cancer (AJCC) / The Union for International Cancer Control (UICC) gastric cancer TNM staging system (8th edition), patients who with gastric cancer in stage II, III and IV; 3.Patients whose inspection indicators are in line with chemotherapy indications and undergoing in chemotherapy treatment; 4.The patients age from 18 to 70 years old, regardless of gender; 5.KPS score is over 60; 6.The estimated survival time is not less than 3 months through symptoms, signs and other auxiliary examinations; 7.The patients have good compliance, understand the real situation of this study, participate voluntarily, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients in perioperative preoperative chemotherapy 2.Pregnant or lactating women; 3..Patients with severe hepatic and renal dysfunction,or combined with severe cardiovascular and cerebrovascular diseases, diabetes, infectious diseases, etc., with obvious bleeding tendency; 4.Patients with poor compliance, or mental disorders cannot cooperate with treatment; 5.Patients have been accepted other therapeutic measures similar to this study, which may interfere with or affect the observation indicators of this trial.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| classification criteria table for acute and subacute toxicity of anticancer drugs made by WHO;Tumor Marker: AFP, CEA, CA125, CA153/PSA, CA199;The results of routine blood test and biochemical test; | — |
Primary
| Measure | Time frame |
|---|---|
| the Index of Nausea, Vomiting and Retching;MD Anderson Symptom Inventory - Traditional Chinese Medicine (MDASI-TCM);European organization for research and treatment of cancer quality of life questionair (EORTC QLQ-C30+STO22);Safety Evaluation; | — |
Countries
China
Contacts
Public ContactPan Lijia
College of Acupuncture and Moxibustion, Hebei University of Chinese Meidicne
Outcome results
None listed